OncoCyte Corp Correlations

OCX Stock  USD 2.01  0.01  0.50%   
The current 90-days correlation between OncoCyte Corp and Burning Rock Biotech is -0.03 (i.e., Good diversification). The correlation of OncoCyte Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

OncoCyte Corp Correlation With Market

Significant diversification

The correlation between OncoCyte Corp and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.

Moving together with OncoCyte Stock

  0.81JNJ Johnson JohnsonPairCorr
  0.88INZY Inozyme PharmaPairCorr
  0.64KRYS Krystal BiotechPairCorr
  0.61LPTX Leap TherapeuticsPairCorr
  0.84MREO Mereo BioPharma GroupPairCorr
  0.85NKTX Nkarta IncPairCorr
  0.92PDSB PDS Biotechnology CorpPairCorr
  0.64PLRX Pliant TherapeuticsPairCorr
  0.93ABOS Acumen PharmaceuticalsPairCorr
  0.79ADAP Adaptimmune TherapeuticsPairCorr
  0.91AFMD Affimed NVPairCorr
  0.62AGIO Agios PharmPairCorr
  0.84AMGN Amgen Inc Earnings Call This WeekPairCorr
  0.83AMLX Amylyx PharmaceuticalsPairCorr
  0.81APTO Aptose BiosciencesPairCorr
  0.69STOK Stoke TherapeuticsPairCorr
  0.76BDTX Black Diamond TherapPairCorr
  0.74TERN Terns Pharmaceuticals Buyout TrendPairCorr
  0.82CRVS Corvus PharmaceuticalsPairCorr
  0.85DAWN Day One BiopharmaceuPairCorr
  0.84ACET Adicet BioPairCorr
  0.82SHG Shinhan Financial Earnings Call This WeekPairCorr
  0.66WF Woori Financial Group Earnings Call This WeekPairCorr

Moving against OncoCyte Stock

  0.77MLAB Mesa Laboratories Earnings Call This WeekPairCorr
  0.53BMY Bristol Myers Squibb Earnings Call This WeekPairCorr
  0.48GILD Gilead Sciences Earnings Call This WeekPairCorr
  0.31MDGL Madrigal PharmaceuticalsPairCorr
  0.52BPMC Blueprint Medicines Corp Sell-off TrendPairCorr
  0.51PTCT PTC TherapeuticsPairCorr
  0.88FNMFO Federal National MortgagePairCorr
  0.77MNPR Monopar TherapeuticsPairCorr
  0.7AVAL Grupo AvalPairCorr
  0.53CIB Bancolombia SA ADRPairCorr
  0.53ITCL Banco Ita ChilePairCorr
  0.52TGNA Tegna IncPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
OLKSTIM
OLKBNR
XGNBNR
CSTLDRIO
PSNLGTH
STIMBNR
  
High negative correlations   
CSTLOLK
CSTLBNR
CSTLSTIM
XGNDRIO
XGNGTH
XGNCSTL

Risk-Adjusted Indicators

There is a big difference between OncoCyte Stock performing well and OncoCyte Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OncoCyte Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BNR  4.82  1.55  0.24  10.02  4.49 
 15.95 
 46.14 
STIM  6.53  2.47  0.23 (2.82) 8.10 
 18.50 
 45.79 
DRIO  6.60  0.24  0.00 (0.07) 8.94 
 9.86 
 121.18 
GTH  1.87  0.02 (0.02)(2.40) 2.49 
 3.45 
 14.43 
SERA  4.01  0.13  0.00 (0.10) 5.47 
 10.39 
 31.68 
OLK  0.63  0.18  0.10 (0.98) 0.48 
 1.58 
 4.37 
FONR  1.40 (0.01)(0.02) 0.08  1.59 
 2.67 
 13.34 
CSTL  2.52 (0.11) 0.00  0.71  0.00 
 4.85 
 23.12 
XGN  5.43  0.86  0.12  2.06  5.58 
 17.67 
 45.67 
PSNL  5.62  0.30  0.07  0.22  6.41 
 9.82 
 55.66 

OncoCyte Corp Corporate Management

Andrea JamesChief OfficerProfile
Ekkehard MDChief OfficerProfile
Joshua RiggsInterim OfficerProfile
Tony KalajianSenior Vice President Chief Accounting OfficerProfile
Andrew LastIndependent DirectorProfile
William AnnettAdvisorProfile